Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors
Diedrich, D., Hamacher, A., Gertzen, C. G. W., Avelar, L. A. Alves, Reiss, G. J., Kurz, T., Gohlke, H., Kassack, M. U., Hansen, F. K.
Published in Chemical communications (Cambridge, England) (01.01.2016)
Published in Chemical communications (Cambridge, England) (01.01.2016)
Get full text
Journal Article
Stability of murine bradykinin type 2 receptor despite treatment with NO, bradykinin, icatibant, or C1‐INH
Khosravani, F., Suvorava, T., Dao, V. T.‐V., Brockmann, N., Kocgirli, O., Herbst, F. F., Valcaccia, S., Kassack, M. U., Bas, M., Kojda, G.
Published in Allergy (Copenhagen) (01.03.2015)
Published in Allergy (Copenhagen) (01.03.2015)
Get full text
Journal Article
Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X receptor antagonist
RETTINGER, J, BRAUN, K, HOCHMANN, H, KASSACK, M, ULLMANN, H, NICKEL, P, SCHMALZING, G, LAMBRECHT, G
Published in Neuropharmacology (01.03.2005)
Published in Neuropharmacology (01.03.2005)
Get full text
Journal Article
In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469
Urban, C., Hamacher, A., Partke, H. J., Roden, M., Schinner, S., Christiansen, E., Due-Hansen, M. E., Ulven, T., Gohlke, H., Kassack, M. U.
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.12.2013)
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.12.2013)
Get full text
Journal Article
Structure-Activity Relationships of Suramin and Pyridoxal-5-phosphate Derivatives as P2 Receptor Antagonists
Lambrecht, Günter, Braun, Kirsten, Damer, MiSusannechelle, Ganso, Matthias, Hildebrandt, Caren, Ullmann, Heiko, Kassack, Matthias U, Nickel, Peter
Published in Current pharmaceutical design (01.12.2002)
Published in Current pharmaceutical design (01.12.2002)
Get full text
Journal Article
Assessment of platinum sensitivity in human tumor cells
Zisowsky, J, Becker, A, Weykam, S, Kassack, M, Jaehde, U
Published in International journal of clinical pharmacology and therapeutics (01.12.2003)
Published in International journal of clinical pharmacology and therapeutics (01.12.2003)
Get more information
Journal Article
Differential gene expression studies in cisplatin-sensitive versus cisplatin-resistant human cancer cell lines
Gosepath, E M, Weykam, S, Gruenewald, E, Ko, Y, Wiese, M, Kassack, M U
Published in International journal of clinical pharmacology and therapeutics (01.11.2004)
Published in International journal of clinical pharmacology and therapeutics (01.11.2004)
Get more information
Journal Article
CAR+ T-cell therapy might serve as a new treatment option for Cisplatin resistant squamous cell carcinoma
Poschinski, Z, Haist, C, Hamacher, A, Kassack, M, Hanenberg, H, Scheckenbach, K
Published in Laryngo-Rhino-Otologie (01.05.2021)
Published in Laryngo-Rhino-Otologie (01.05.2021)
Get full text
Conference Proceeding
Suramin Derivatives as Inhibitors and Activators of Protein-tyrosine Phosphatases
McCain, Daniel F., Wu, Li, Nickel, Peter, Kassack, Matthias U., Kreimeyer, Annett, Gagliardi, Antonio, Collins, Delwood C., Zhang, Zhong-Yin
Published in The Journal of biological chemistry (09.04.2004)
Published in The Journal of biological chemistry (09.04.2004)
Get full text
Journal Article
Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitorsElectronic supplementary information (ESI) available: Experimental details (synthetic protocols, bioassays, X-ray crystallography, computational methods), characterization data of new compounds, and copies of NMR spectra. CCDC 1434499. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5cc10301k
Diedrich, D, Hamacher, A, Gertzen, C. G. W, Alves Avelar, L. A, Reiss, G. J, Kurz, T, Gohlke, H, Kassack, M. U, Hansen, F. K
Year of Publication 11.02.2016
Year of Publication 11.02.2016
Get full text
Journal Article
Stability of murine bradykinin type 2 receptor despite treatment with NO , bradykinin, icatibant, or C 1‐ INH
Khosravani, F., Suvorava, T., Dao, V. T.‐V., Brockmann, N., Kocgirli, O., Herbst, F. F., Valcaccia, S., Kassack, M. U., Bas, M., Kojda, G.
Published in Allergy (Copenhagen) (01.03.2015)
Published in Allergy (Copenhagen) (01.03.2015)
Get full text
Journal Article
Effects of NO on the expression and function of bradykinin type 2 receptors. Role for angioedema?
Khosravani, F., Suvorava, T., Brockmann, N., Dao, V. T., Bisha, M., Kassack, M., Bas, M., Kojda, G.
Published in European heart journal (02.08.2013)
Published in European heart journal (02.08.2013)
Get full text
Journal Article
CAR+ T-Zell Therapie als mögliche neue Therapieoption für Cisplatin-resistente Plattenepithelkarzinome
Poschinski, Z, Haist, C, Hamacher, A, Kassack, M, Hanenberg, H, Scheckenbach, K
Published in Laryngo-Rhino-Otologie (01.05.2021)
Published in Laryngo-Rhino-Otologie (01.05.2021)
Get full text
Conference Proceeding
The novel suramin analogue NF864 selectively blocks P2X(1) receptors in human platelets with potency in the low nanomolar range
Horner, S, Menke, K, Hildebrandt, C, Kassack, M, Nickel, P, Ullmann, H, Mahaut-Smith, M, Lambrecht, G
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.07.2005)
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.07.2005)
Get full text
Journal Article
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors
Braun, K, Rettinger, J, Ganso, M, Kassack, M, Hildebrandt, C, Ullmann, H, Nickel, P, Schmalzing, G, Lambrecht, G
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.09.2001)
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.09.2001)
Get full text
Journal Article